Dr. Kevin Pearlstein (PGY 4)

Education

  • Undergraduate: Tufts University, Boston, MA
  • Medical School: University of North Carolina School of Medicine, Chapel Hill, NC
  • Internship: University of North Carolina Hospitals, Chapel Hill, NC


Research Interests

Genitourinary cancers, treatment complications and patient quality of life


Publications
(as of 9/12/17)

  • Ye F, Moon DH, Carpenter WR, Reeve BB, Usinger DS, Green RL, Spearman K, Sheets NC, Pearlstein KA, Lucero AR, Waddle MR, Godley PA, Chen RC.  Comparison of patient report and medical records of comorbidities: results from a population-based cohort of patients with prostate cancer. JAMA Oncol 2017 Aug 1;3(8):1035-1042. PMID: 28208186.

  • Diao K, Lobos EA, Yirmibesoglu E, Basak R, Hendrix LH, Barbosa B, Miller SMPearlstein KAGoldin GH, Wang AZ, Chen RC.  Patient-reported quality of life during definitive and post-prostatectomy image-guided radiation therapy for prostate cancer.  Pract Radiat Oncol 2017 Mar-Apr;7(2):e117-e124. [ePub], PMID: 28274402.

  • Pearlstein KA, Chen RC. Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer. Semin Radiat Oncol 2013 Jul;23(3):182-190. PMID: 23763884.

  • Ye F, Moon DH, Carpenter WR, Reeve BB, Usinger DS, Green RL, Spearman K, Sheets NC, Pearlstein KA, Lucero AR, Waddle MR, Godley PA, Chen RC.  Comparison of patient report and medical records of comorbidities: results from a population-based cohort of patients with prostate cancer. JAMA Oncol 2017 Feb 16. [Epub ahead of print]. PMID: 28208186.

  • Kidd JM, Gravel S, Byrnes J, Moreno-Estrada A, Musharoff S, Bryc K, Degenhardt JD, Brisbin A, Sheth V, Chen R, McLaughlin SF, Peckham HE, Omberg L, Bormann Chung CA, Stanley S, Pearlstein K, et al. Population genetic inference from personal genome data: impact of ancestry and admixture on human genomic variation. Am J Human Genet 2012 Oct; 91(4):660-671. PMID: 23040495.

  • Katz LM, Nauriyal V, Nagaraj S, Finch A, Pearlstein K, et al. Infrared imaging of trauma patients for detection of acute compartment syndrome of the leg. Crit Care Med 2008 Jun;36(6):1756-1761. PMID: 18496371.


Meeting Abstracts/Presentations (recent)

  • Wang K, Pearlstein KA, Mahbooba Z, Sutton S, et al.   Xerostomia is an unrecognized complication of whole brain radiotherapy and may be related to parotid dose: A prospective observational trial.  American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.) 
  • Wang K, Pearlstein KA, Patchett ND, Deal A, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.  American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
  • Pearlstein KA, Basak R, Chen RC. Cardiovascular disease and preventive care among cancer survivors: A population-based study. American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 2-6, 2017.  (Poster presentation.)
  • Pearlstein KA, Basak R, Saripalli S, Sun JK, et al. Trajectory of patient-reported urinary and bowel symptom development during modern postprostatectomy radiation therapy.  American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Pearlstein KA, Ramsankar Basak R, Chen RC. Breast cancer patient functional status and comorbidities and their impact on treatment aggressiveness: A population-based study. American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 3-7, 2016. (Poster presentation.)
  • Pearlstein KA, Hendrix LH, Chen RC. Patient-level characteristics of Medicare cancer patients in the United States: Implications for treatment and survivorship. American Society for Radiation Oncology Annual Meeting, Atlanta, GA, September 22-25, 2013. (Poster presentation.)
  • Pearlstein KA, Hendrix LH, Chen RC. Prevalence of cardiovascular disease (CVD) risk factors and preventive care among U.S. cancer survivors. American Society for Clinical Oncology Annual Meeting, Chicago, IL, May 31 - June 4, 2013. (Poster presentation.)
  • Barbosa BD, Hendrix LH, Pearlstein KA, Chen RC. Treatment patterns for patients with localized (T1-T2) penile squamous cell carcinoma in the United States. American Society of Clinical Oncology Genitourinary Symposium, Orlando, FL, February 14–16, 2013. (Poster presentation.)
  • Pearlstein KA, Hendrix LH, Royce TJ, Stokes WA, Chen RC. Prevalence of cardiovascular disease (CVD) risk factors and receipt of preventive care among prostate cancer (CaP) survivors in the United States. American Society of Clinical Oncology Genitourinary Symposium, Orlando, FL, February 14–16, 2013. (Poster presentation.)
  • Pearlstein KA, Hendrix LH, Chen RC. Quality cancer survivorship care: Receipt of guideline recommended cardiovascular disease (CVD) preventive care among healthy cancer survivors in the United States. American Society for Clinical Oncology Quality Care Symposium, San Diego, CA, November 30 - December 1, 2012. (Poster presentation.)